Sign Out
Hypersensitivity to the active substance or to any of the excipients listed in Description.
Serum albumin <2.8 g/dL (see Precautions regarding use in patients with serum albumin ≥2.8 g/dL).
Coadministration of medicinal products that are strong inducers of CYP3A4 (e.g. carbamazepine).
Continue with Google